02135 RAILY AESMED
- 0.153
- +0.001+0.66%
RAILY AESMED News
Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) 53% Dip In Price Shows Sentiment Is Matching Revenues
To the annoyance of some shareholders, Raily Aesthetic Medicine International Holdings Limited (HKG:2135) shares are down a considerable 53% in the last month, which continues a horrid run for the com
Ruili Medical & Aesthetic (02135.HK) issued and allotted approximately 139 million new shares under the share offering
On April 25, Ge Longhui (02135.HK) issued an announcement. On April 25, 2024, approximately 139 million new shares will be issued and allocated in accordance with the share offering.
Ruili Medical Aesthetic (02135): The share offering was oversubscribed by about 31.7% and raised about HK$19.2 million
According to Zhitong Finance App News, Ruili Medical & Aesthetic (02135) announced that since all conditions contained in the underwriting agreement have been met, and the underwriter did not terminate the underwriting agreement before the final termination time limit, the stock offering was becoming unconditional at 4:00 p.m. on April 18, 2024 (Thursday). The net proceeds from the stock offering were approximately HK$19.2 million. In total, it has received 8 provisional quota notices and valid applications under additional application forms, involving a total of approximately 183 million shares offered, which is equivalent to about 131.7% of the total number of shares offered for subscription under the offering. Based on the above results, shares were sold
瑞麗醫美(新)：2023年報
Ruili Medical & Aesthetic (02135) announced annual results, loss attributable to shareholders of 32.457 million yuan, an increase of 103.99% year-on-year
According to the Zhitong Finance App, Ruili Medical & Aesthetic (02135) announced annual results for the year ended December 31, 2023. The group achieved revenue of 189 million yuan (RMB, same below) during the period, an increase of 15.11% over the previous year; losses attributable to shareholders were 32.457 million yuan, an increase of 103.99% over the previous year; and the basic loss per share was 7.77 points. According to the announcement, the main reason for the increase in revenue and continued losses is that in the first month of 2023, the business of medical institutions in Zhejiang and Anhui regions was still affected by the large-scale COVID-19 outbreak, which prevented most customers from visiting the group's institutions, making the company
瑞麗醫美：截至2023年12月31日止年度年度業績公告
Ruili Medical & Aesthetic (02135) cut 1,671 billion shares due to share consolidation on a “5 and 1” basis
Ruili Medical & Aesthetic (02135) issued an announcement to cut 1,671 billion shares due to share consolidation on a “5 and 1” basis...
Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) 39% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) shares have had a horrible month, losing 39% after a relatively good period beforehand. The recent drop completes a disastrous twe
Ruili Medical & Aesthetic (02135): The share merger will take effect on March 19
Ruili Medical & Aesthetic (02135) issued an announcement. Since all conditions for the share merger have been met, the share merger will be 202...
[Company Profit Alert] Ruili Medical Aesthetic (02135) expects losses to increase to 32 million yuan last year
Jinwu Financial News | Ruili Medical & Aesthetic (02135) issued a profit warning. The Group expects revenue of approximately RMB 189 million for the year ended December 31, 2023 (2022: revenue of approximately RMB 165 million); and for the year ended December 31, 2023, losses attributable to owners of the parent company were approximately RMB 32 million. In the same period last year, parent company owners should account for losses of approximately RMB 16 million. According to the announcement, the continued loss was mainly due to the first month of 2023. The business of medical institutions in Zhejiang and Anhui was still affected by the large-scale COVID-19 outbreak, leading to the majority
Raily Aesthetic Medicine Forecasts Wider Loss in 2023
Raily Aesthetic Medicine International Holdings (HKG:2135) forecasts its loss to widen to 32 million yuan in 2023 from 16 million yuan in 2022, according to a Thursday filing with the Hong Kong bourse
Ruili Medical Aesthetic (02135) Fa Ying Guang expects losses due to parent company owners of about 32 million yuan to double year-on-year in 2023
Ruili Medical & Aesthetic (02135) announced that the group expects revenue of about RMB 189 million in 2023, an increase over the previous year...
Gelonghui Announcement Selection (Hong Kong Stock) | Ideal Automobile-W (02015.HK) turned a loss into profit for the first time in 2023 and achieved a healthy profit. Cash reserves have increased to 103.67 billion yuan
[Today's Focus] Ideal Automobile-W (02015.HK) turned a loss into profit for the first time in 2023 and achieved a healthy profit. Cash reserves have increased to 103.67 billion yuan Ideal Automobile-W (02015.HK) announced unaudited financial results for the quarter and full year ended December 31, 2023. In the fourth quarter of 2023, vehicle sales revenue was RMB 40.38 billion, up 133.8% year on year, up 20.1% month on month; total revenue was RMB 41.73 billion, up 136.4% year on year, up 20.3% month on month; gross profit was RMB 97.9
Ruili Medical & Aesthetic (02135.HK) proposes a “3 to 1” share offering for the “5 in 1” consolidated shares
On February 26, Gelonghui (02135.HK) issued an announcement. The board of directors proposed a share consolidation based on the basis of merging every 5 existing shares in the company's share capital into 1 consolidated share. The share consolidation is subject to approval by shareholders by voting at the special shareholders' meeting before it can actually take place. The Company proposes to issue up to 141 million shares of the offering at a subscription price of HK$0.148 per share of the 3 consolidated shares held by eligible shareholders, with a maximum total proceeds of approximately HK$20.8 million (before deducting expenses) through a share offering. Net proceeds from the sale of shares
Ruili Medical & Aesthetic (02135.HK) grants 47.43 million share options
Gelonghui, Feb. 23 | Ruili Medical & Aesthetic (02135.HK) announced that after the 47.43 million share options previously granted by the company expired, the board of directors has decided to grant 47.43 million share options to certain eligible persons (i.e. six employees of the Group) in accordance with the share option plan adopted by the shareholders on December 4, 2020. The exercise price of the shares was HK$0.122 per share.
Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Shares Climb 31% But Its Business Is Yet to Catch Up
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) shares have had a really impressive month, gaining 31% after a shaky period beforehand. Not all shareholders will be feeling jubil
Ruili Medical & Aesthetic (02135.HK) grants 48.63 million share options
Gelonghui, January 26, 丨 Ruili Medical Beauty (02135.HK) issued an announcement. The board of directors has decided to grant 48.63 million share options to a number of eligible persons (that is, the three employees of the Group) in accordance with the share option plan adopted by the shareholders on December 4, 2020. The exercise price of the share options is HK$0.115 per share.
RAILY AESMED: Interim Report 2023
Ruili Medical Beauty (02135) released its interim results, with revenue of 97.58 million yuan, an increase of 3.37% over the previous year
Ruili Medical Beauty (02135) announced the interim results for the 6 months ended June 30, 2023. During the reporting period, it received...
RAILY AESMED: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Analysis
Price Target
No Data
